Adjuvant atezolizumab after adjuvant chemotherapy in resected stage IB–IIIA non-small-cell lung cancer (IMpower010): a randomised, multicentre, open-label, phase 3 trial
収録刊行物
-
- The Lancet
-
The Lancet 398 (10308), 1344-1357, 2021-10
Elsevier BV